Advanced in Appendix Cancer

Dr. Jeffrey A. Meyerhardt

Oncology
Brigham and Women’s Hospital
Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, 
Chestnut Hill, MA 

Advanced in Appendix Cancer
Brigham and Women’s Hospital
Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, 
Chestnut Hill, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Meyerhardt is an Oncologist in Chestnut Hill, Massachusetts. Dr. Meyerhardt is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Lynch Syndrome, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 410 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Appendix Cancer.

Graduate Institution
Yale University, 1997
Residency
Beth Israel Deaconess Hospital, 1997 - 2000
Specialties
Oncology
Licenses
Internal Medicine in MA
Board Certifications
Medical Oncology
Fellowships
Dana Farber Cancer Institute******, 2000 - 2002
Hospital Affiliations
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Trustmark
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, Chestnut Hill, MA 02459
Call: 617-632-6855
Other Locations
Dana-Farber Cancer Institute, Center for Gastrointestinal Oncology
450 Brookline Avenue, Boston, MA 02115
Call: 617-632-6855

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Cisplatin, Gemcitabine, Nab-Paclitaxel
Study Phase: Phase 3
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Phase: Phase 3
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Colorectal Cancer
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Colorectal Cancer
Enrollment Status: Unknown
Publish Date: September 08, 2022
Intervention Type: Drug, Radiation
Study Phase: Phase 2
A Pilot Study of Physical Activity in Older Adults With Metastatic Gastrointestinal Cancer
A Pilot Study of Physical Activity in Older Adults With Metastatic Gastrointestinal Cancer
Enrollment Status: Completed
Publish Date: March 12, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

410 Total Publications

Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 04, 2025
View All 410 Publications
Similar Doctors
Distinguished in Appendix Cancer
Dr. Jill N. Allen
Oncology
Distinguished in Appendix Cancer
Dr. Jill N. Allen
Oncology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (28.4 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jill Allen is an Oncologist in Boston, Massachusetts. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Anal Cancer, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Allen is currently accepting new patients.

Distinguished in Appendix Cancer
Dr. Jennifer A. Chan
Oncology
Distinguished in Appendix Cancer
Dr. Jennifer A. Chan
Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (25.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Chan is an Oncologist in Boston, Massachusetts. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. Her top areas of expertise are Neuroendocrine Tumor, Metastatic Insulinoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Pancreatic Islet Cell Tumor. Dr. Chan is currently accepting new patients.

Advanced in Appendix Cancer
Dr. Douglas A. Rubinson
Oncology
Advanced in Appendix Cancer
Dr. Douglas A. Rubinson
Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (25.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Rubinson is an Oncologist in Boston, Massachusetts. Dr. Rubinson is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Rubinson is currently accepting new patients.

VIEW MORE APPENDIX CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Meyerhardt's expertise for a condition
ConditionClose
  • Elite
  • Colorectal Cancer
    Dr. Meyerhardt is
    Elite
    . Learn about Colorectal Cancer.
    See more Colorectal Cancer experts
  • Distinguished
  • Familial Colorectal Cancer
    Dr. Meyerhardt is
    Distinguished
    . Learn about Familial Colorectal Cancer.
    See more Familial Colorectal Cancer experts
  • Lynch Syndrome
    Dr. Meyerhardt is
    Distinguished
    . Learn about Lynch Syndrome.
    See more Lynch Syndrome experts
  • Pancreatic Cancer
    Dr. Meyerhardt is
    Distinguished
    . Learn about Pancreatic Cancer.
    See more Pancreatic Cancer experts
  • Advanced
  • Anal Cancer
    Dr. Meyerhardt is
    Advanced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Appendix Cancer
    Dr. Meyerhardt is
    Advanced
    . Learn about Appendix Cancer.
    See more Appendix Cancer experts
  • Cholangiocarcinoma (Bile Duct Cancer)
    Dr. Meyerhardt is
    Advanced
    . Learn about Cholangiocarcinoma (Bile Duct Cancer).
    See more Cholangiocarcinoma (Bile Duct Cancer) experts
  • Familial Pancreatic Cancer
    Dr. Meyerhardt is
    Advanced
    . Learn about Familial Pancreatic Cancer.
    See more Familial Pancreatic Cancer experts
  • Liver Cancer
    Dr. Meyerhardt is
    Advanced
    . Learn about Liver Cancer.
    See more Liver Cancer experts
  • Neuroendocrine Tumor
    Dr. Meyerhardt is
    Advanced
    . Learn about Neuroendocrine Tumor.
    See more Neuroendocrine Tumor experts
View All 8 Advanced Conditions
  • Experienced
  • Agranulocytosis
    Dr. Meyerhardt is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Ampullary Cancer
    Dr. Meyerhardt is
    Experienced
    . Learn about Ampullary Cancer.
    See more Ampullary Cancer experts
  • Breast Cancer
    Dr. Meyerhardt is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Meyerhardt is
    Experienced
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Esophageal Cancer
    Dr. Meyerhardt is
    Experienced
    . Learn about Esophageal Cancer.
    See more Esophageal Cancer experts
  • Febrile Neutropenia
    Dr. Meyerhardt is
    Experienced
    . Learn about Febrile Neutropenia.
    See more Febrile Neutropenia experts
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.